LV-GB Complex™ | Stuðningur við lifur...

1. Abenavoli L, Izzo AA, Milić N, Cicala C, Santini A, Capasso R. Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res. 2018;32(11):2202‑2213. doi:10.1002/ptr.6171

2. Bijak M. Silybin, a major bioactive component of milk thistle (Silybum marianum L. Gaernt.) — chemistry, bioavailability, and metabolism. Molecules. 2017;22(11):1942. doi:10.3390/molecules22111942

3. Federico A, Dallio M, Loguercio C. Silymarin/silybin and chronic liver disease: a marriage of many years. Molecules. 2017;22(2):191. doi:10.3390/molecules22020191

4. Vargas‑Mendoza N. Hepatoprotective effect of silymarin. World J Hepatol. 2014;6(3):144. doi:10.4254/wjh.v6.i3.144

5. Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res. 2010;24(10):1423‑1432. doi:10.1002/ptr.3207

6. Gillessen A, Schmidt HHJ. Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther. 2020;37(4):1279‑1301. doi:10.1007/s12325‑020‑01251‑y

7. Faulstich H, Jahn W, Wieland T. Silybin inhibition of amatoxin uptake in the perfused rat liver. Arzneimittelforschung. 1980;30(3):452‑454.

8. Hodges RE, Minich DM. Modulation of metabolic detoxification pathways using foods and food‑derived components: a scientific review with clinical application. J Nutr Metab. 2015;2015:1‑23. doi:10.1155/2015/760689

9. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N‑acetylcysteine‑‑a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355‑359. doi:10.1016/j.coph.2007.04.005

10. Dehmlow C, Erhard J, De Groot H. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology. 1996;23(4):749‑754. doi:10.1002/hep.510230415

11. Lieber CS. S‑adenosyl‑l‑methionine: its role in the treatment of liver disorders. Am J Clin Nutr. 2002;76(5):1183S‑1187S. doi:10.1093/ajcn/76/5.1183S

12. Feld JJ, Modi AA, El‑Diwany R, et al. S‑adenosyl methionine improves early viral responses and interferon‑stimulated gene induction in hepatitis C nonresponders. Gastroenterology. 2011;140(3):830‑839. doi:10.1053/j.gastro.2010.09.010

13. Saénz Rodriguez T, García Giménez D, de la Puerta Vázquez R. Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats. Phytomedicine. 2002;9(8):687‑693. doi:10.1078/094471102321621278

14. Rangboo V, Noroozi M, Zavoshy R, Rezadoost SA, Mohammadpoorasl A. The effect of artichoke leaf extract on alanine aminotransferase and aspartate aminotransferase in the patients with nonalcoholic steatohepatitis. Int J Hepatol. 2016;2016:1‑6. doi:10.1155/2016/4030476

15. Srivastava S, Siddiqi Z, Singh T, Bala L. Beetroot supplementation on non‑alcoholic fatty liver disease patients. Curr Res Nutr Food Sci J. 2019;7(1):96‑101. doi:10.12944/CRNFSJ.7.1.10

16. Krajka‑Kuźniak V, Szaefer H, Ignatowicz E, Adamska T, Baer‑Dubowska W. Beetroot juice protects against N‑nitrosodiethylamine‑induced liver injury in rats. Food Chem Toxicol. 2012;50(6):2027‑2033. doi:10.1016/j.fct.2012.03.062

17. Krajka‑Kuźniak V, Paluszczak J, Szaefer H, Baer‑Dubowska W. Betanin, a beetroot component, induces nuclear factor erythroid‑2‑related factor 2‑mediated expression of detoxifying/antioxidant enzymes in human liver cell lines. Br J Nutr. 2013;110(12):2138‑2149. doi:10.1017/S0007114513001645

18. Albasher G, Almeer R, Al‑Otibi FO, Al‑Kubaisi N, Mahmoud AM. Ameliorative effect of Beta vulgaris root extract on chlorpyrifos‑induced oxidative stress, inflammation and liver injury in rats. Biomolecules. 2019;9(7):261. doi:10.3390/biom9070261

19. Wang DQH. Therapeutic uses of animal biles in traditional Chinese medicine: an ethnopharmacological, biophysical chemical and medicinal review. World J Gastroenterol. 2014;20(29):9952. doi:10.3748/wjg.v20.i29.9952

20. Gruy‑Kapral C, Little KH, Fordtran JS, Meziere TL, Hagey LR, Hofmann AF. Conjugated bile acid replacement therapy for short‑bowel syndrome. Gastroenterology. 1999;116(1):15‑21. doi:10.1016/S0016‑5085(99)70223‑4

21. Little KH, Schiller LR, Bilhartz LE, Fordtran JS. Treatment of severe steatorrhea with ox bile in an ileectomy patient with residual colon. Dig Dis Sci. 1992;37(6):929‑933. doi:10.1007/BF01300393

22. Duszka K. Versatile triad alliance: bile acid, taurine and microbiota. Cells. 2022;11(15):2337. doi:10.3390/cells11152337

23. Guo J, Gao Y, Cao X, Zhang J, Chen W. Cholesterol‑lowing effect of taurine in HepG2 cell. Lipids Health Dis. 2017;16(1):56. doi:10.1186/s12944‑017‑0444‑3

24. Murakami S, Fujita M, Nakamura M, et al. Taurine ameliorates cholesterol metabolism by stimulating bile acid production in high‑cholesterol‑fed rats. Clin Exp Pharmacol Physiol. 2016;43(3):372‑378. doi:10.1111/1440‑1681.12534

25. Chen G. The link between hepatic vitamin A metabolism and nonalcoholic fatty liver disease. Curr Drug Targets. 2015;16(12):1281‑1292. doi:10.2174/1389450116666150325231015

26. Saeed A, Dullaart R, Schreuder T, Blokzijl H, Faber K. Disturbed vitamin A metabolism in non‑alcoholic fatty liver disease (NAFLD). Nutrients. 2017;10(1):29. doi:10.3390/nu10010029

27. Xiang L, Wang X, Jiao Q, et al. Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A‑derivative decorated camptothecin micelles. Acta Biomater. 2023;168:497‑514. doi:10.1016/j.actbio.2023.07.035

28. Sun WL, Hua S, Li XY, Shen L, Wu H, Ji HF. Microbially produced vitamin B12 contributes to the lipid‑lowering effect of silymarin. Nat Commun. 2023;14(1):477. doi:10.1038/s41467‑023‑36079‑x

29. Shimada M, Ichigo Y, Shirouchi B, et al. Treatment with myo‑inositol attenuates binding of the carbohydrate‑responsive element‑binding protein to the ChREBP‑β and FASN genes in rat nonalcoholic fatty liver induced by high‑fructose diet. Nutr Res. 2019;64:49‑55. doi:10.1016/j.nutres.2019.01.002

30. Foster SR, Dilworth LL, Thompson RK, Alexander‑Lindo RL, Omoruyi FO. Effects of combined inositol hexakisphosphate and inositol supplement on antioxidant activity and metabolic enzymes in the liver of streptozotocin‑induced type 2 diabetic rats. Chem Biol Interact. 2017;275:108‑115. doi:10.1016/j.cbi.2017.07.024